Table 1 Patients clinicopathological characteristics
From: Novel prognostic indicator combining inflammatory indicators and tumor markers for gastric cancer
Variables | n (%) or median (IQR) |
|---|---|
Sex | |
 Female | 114 (26.82%) |
 Male | 311 (73.18%) |
Age | |
 <65years | 216 (50.82%) |
 ≥65years | 209 (49.18%) |
Tumor size | |
 <5cm | 257 (60.47%) |
 ≥5cm | 168 (39.53%) |
Differentiation | |
 Moderate/well | 241 (56.71%) |
 Poor | 184 (43.29%) |
Borrmann type | |
 I–II | 230 (54.12%) |
 III–IV | 195 (45.88%) |
Tumor depth | |
 T1 | 45 (10.59%) |
 T2 | 47 (11.06%) |
 T3 | 230 (54.12%) |
 T4 | 103 (24.24%) |
Lymph node | |
 N0 | 100 (23.53%) |
 N1 | 181 (42.59%) |
 N2 | 103 (24.24%) |
 N3 | 41 (9.65%) |
Distant metastasis | |
 M0 | 393 (92.47%) |
 M1 | 32 (7.53%) |
pTNM stage | |
 I | 68 (16.00%) |
 II | 162 (38.12%) |
 III | 163 (38.35%) |
 IV | 32 (7.53%) |
CEA | |
 ≤5ng/ml | 276 (64.94%) |
 >5ng/ml | 149 (35.06%) |
CA19-9 | |
 ≤37U/ml | 317 (74.59%) |
 >37U/ml | 108 (25.41%) |
NLR | 2.71 (1.73–4.46) |
PLR | 136.8 (94.0–207.6) |
LMR | 4.46 (2.87–6.27) |